相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel mechanism for inhibition of lipopolysaccharide-induced proinflammatory cytokine production by valproic acid
Ulziisaikhan Jambalganiin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Topical valproic acid increases the hair count in male patients with androgenetic alopecia: A randomized, comparative, clinical feasibility study using phototrichogram analysis
Seong Jin Jo et al.
JOURNAL OF DERMATOLOGY (2014)
Valproic Acid Use During Radiation Therapy for Glioblastoma Associated With Improved Survival
Christopher A. Barker et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Valproic acid promotes human hair growth in in vitro culture model
Seong Jin Jo et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2013)
Valproic acid: Growth inhibition of head and neck cancer by induction of terminal differentiation and senescence
Chai Phei Gan et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
Valproic acid sensitizes human glioma cells for temozolomide and γ-radiation
Krista A. Van Nifterik et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Valproic Acid Induces Hair Regeneration in Murine Model and Activates Alkaline Phosphatase Activity in Human Dermal Papilla Cells
Soung-Hoon Lee et al.
PLOS ONE (2012)
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma
M. Weller et al.
NEUROLOGY (2011)
Histone Deacetylase Inhibitors Suppress the Expression of Inflammatory and Innate Immune Response Genes in Human Microglia and Astrocytes
Hyeon-Sook Sub et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines
Jun Fu et al.
NEURO-ONCOLOGY (2010)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Practice Parameter update: Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society
C. L. Harden et al.
NEUROLOGY (2009)
Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway
Gyung-Ah Jung et al.
BMC CELL BIOLOGY (2008)
Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments
K. N. Harikrishnan et al.
CELL CYCLE (2008)
Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control
Srividya Bhaskara et al.
MOLECULAR CELL (2008)
Histone deacetylase inhibitors protect against and mitigate the lethality of total-body irradiation in mice
Stephen L. Brown et al.
RADIATION RESEARCH (2008)
The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?
G. Rosenberg
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors:: A clinical and translational study
Pamela Muenster et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management
Melanie S. M. van Breemen et al.
LANCET NEUROLOGY (2007)
Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: A review
M. F. Reynolds et al.
CURRENT MEDICINAL CHEMISTRY (2007)
WNT and DKK determine hair follicle spacing through a reaction-diffusion mechanism
Stefanie Sick et al.
SCIENCE (2006)
Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity
A Munshi et al.
CLINICAL CANCER RESEARCH (2005)
Valproic acid alters chromatin structure by regulation of chromatin modulation proteins
DC Marchion et al.
CANCER RESEARCH (2005)
Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease.: A study of the Spanish Medical Neuro-Oncology Group (GENOM)
C Balaña et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells
J Hsieh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3
TD Gould et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition
MR Jeong et al.
FEBS LETTERS (2003)
Cultured peribulbar dermal sheath cells can induce hair follicle development and contribute to the dermal sheath and dermal papilla
KJ McElwee et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons
AC Hall et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2002)
WNT signals are required for the initiation of hair follicle development
T Andl et al.
DEVELOPMENTAL CELL (2002)
Molecular mechanisms regulating hair follicle development
SE Millar
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Dynamic expression and nuclear accumulation of β-catenin during the development of hair follicle-derived structures
M Ridanpää et al.
MECHANISMS OF DEVELOPMENT (2001)
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen
CJ Phiel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
β-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin
J Huelsken et al.
CELL (2001)
分享论文
